Kits Eyecare Ltd. (TSX:KITS)
Canada
· Delayed Price · Currency is CAD | Market Cap | 497.57M |
| Revenue (ttm) | 202.46M |
| Net Income (ttm) | 3.11M |
| Shares Out | 33.99M |
| EPS (ttm) | 0.09 |
| PE Ratio | 162.67 |
| Forward PE | 57.98 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 65,352 |
| Average Volume | 84,904 |
| Open | 14.99 |
| Previous Close | 14.64 |
| Day's Range | 14.15 - 14.99 |
| 52-Week Range | 11.00 - 22.56 |
| Beta | 0.22 |
| RSI | 37.98 |
| Earnings Date | May 6, 2026 |
About Kits Eyecare
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada. [Read more]
Financial Performance
In 2025, Kits Eyecare's revenue was 202.46 million, an increase of 27.06% compared to the previous year's 159.34 million. Earnings were 3.11 million, a decrease of -0.19%.
Financial StatementsNews
Kits Eyecare Earnings Call Transcript: Q4 2025
Q4 and FY 2025 saw record revenue and profitability, driven by strong growth in glasses, contact lenses, and AI glasses, with expanding gross margins and high repeat customer rates. The company remains debt-free, well-capitalized, and is guiding for continued growth in 2026.
Kits Eyecare Earnings Call Transcript: Q3 2025
Record Q3 revenue grew 25% year-over-year, with strong Canadian performance and 12th straight positive Adjusted EBITDA quarter. KITS branded contact lenses and premium lenses drove high-margin growth, while U.S. investment is set to resume as market conditions stabilize.
Kits Eyecare Earnings Call Transcript: Q2 2025
Q2 2025 saw record revenue and customer growth, with strong gains in glasses and premium lens upgrades, improved gross margin, and continued positive adjusted EBITDA. Guidance for Q3 projects further revenue and margin expansion, supported by technology innovation and efficient capital management.
Kits Eyecare Transcript: AGM 2025
The meeting confirmed quorum, presented financial statements, and re-elected all six director nominees. MNP LLP was reappointed as auditor, and all resolutions were approved by shareholders. Voting results will be published on SEDAR+ and the company website.
Kits Eyecare Earnings Call Transcript: Q1 2025
Q1 saw record revenue and gross profit growth, with all segments expanding over 30% year-over-year and strong repeat customer metrics. Guidance for Q2 remains robust, with continued investment in customer acquisition and operational efficiency, and inventory normalization expected by Q3.
Kits Eyecare Transcript: Planet MicroCap Showcase: VEGAS 2025
A vertically integrated, online eyewear provider is leveraging automation, data, and creative marketing to disrupt a $70 billion market, achieving 35% organic growth and strong customer retention. With scalable infrastructure and a focus on premium segments, it targets $500 million revenue and 15–20% EBITDA in five years.
Kits Eyecare Earnings Call Transcript: Q4 2024
Q4 revenue grew 42% year-over-year to CAD 44.8 million, with adjusted EBITDA margin at 6.5%. Glasses segment surged 60%, and customer loyalty drove 63% of Q4 revenue. Guidance for Q1 2025 projects continued growth and margin expansion.
Kits Eyecare Earnings Call Transcript: Q3 2024
Q3 2024 saw record revenue of CAD 41.9 million (34% YoY growth), strong Adjusted EBITDA, and robust customer expansion, with both U.S. and Canadian markets delivering double-digit growth. Guidance for Q4 projects continued momentum, supported by product innovation and operational efficiency.
Kits Eyecare Transcript: Planet MicroCap Showcase: VANCOUVER 2024
Sustained 30% organic growth and operational efficiency have been driven by automation, data, and a customer-centric approach. Influencer and localized marketing strategies have delivered strong ROI, while recurring revenue and insurance partnerships support long-term growth.
Kits Eyecare Transcript: 2024 Annual Gateway Conference
A vertically integrated digital eye care platform is achieving rapid, profitable growth by targeting millennials, leveraging automation, and maintaining high customer retention. Raised Q3 revenue guidance above CAD 41 million, with expanding margins and minimal future CapEx. Insurance integration and a scalable infrastructure support ambitious multi-year growth targets.
Kits Eyecare Earnings Call Transcript: Q2 2024
Record Q2 revenue of nearly CAD 38 million marked 26% year-over-year growth, with strong gains in both contact lens and eyeglasses segments. Guidance for Q3 projects continued robust growth and margin expansion, supported by product innovation and network effects.
Kits Eyecare Transcript: RBC Capital Markets Consumer & Retail Day 2024
A rapidly growing online optical retailer has disrupted the $80B North American market with low prices, in-house manufacturing, and a focus on recurring revenue. Strategic partnerships, influencer marketing, and a scalable lab underpin strong profitability and ambitious growth targets.